Griseofulvin should remain standard in tinea capitis

January 1, 2002

Munich - Newer oral antifungals have efficacy similar to griseofulvin in tinea capitis, possibly with a shorter duration of therapy. But for now, the old and familiar standby should remain the treatment of choice, according to Peter Mayser, M.D., senior physician, Justus Liebig University, Giessen, Germany.

Related Content:

News